The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Fresenius Medical Care AG & Co KGaA

NYSE: FMS
Last

(U.S.) $43.57

Today's change+0.22 +0.51%
Updated June 30 4:02 PM EDT. Delayed by at least 15 minutes.
 

Fresenius Medical Care AG & Co KGaA

NYSE: FMS
Last

(U.S.) $43.57

Today's change+0.22 +0.51%
Updated June 30 4:02 PM EDT. Delayed by at least 15 minutes.

Fresenius Medical Care AG & Co KGaA up (U.S.)$0.22

Fresenius Medical Care AG & Co KGaA closed up Thursday by (U.S.)$0.22 or 0.51% to (U.S.)$43.57. Over the last five days, shares have gained 0.72% and are currently 4.97% off of the 52-week high. Shares have outperformed the S&P 500 by 3.03% during the last year.

Key company metrics

  • Open(U.S.) $43.18
  • Previous close(U.S.) $43.35
  • High(U.S.) $43.59
  • Low(U.S.) $43.04
  • Bid / Ask(U.S.) $39.83 / (U.S.) $47.29
  • YTD % change+4.13%
  • Volume133,668
  • Average volume (10-day)231,033
  • Average volume (1-month)170,694
  • Average volume (3-month)154,662
  • 52-week range(U.S.) $36.89 to (U.S.) $45.85
  • Beta0.58
  • Trailing P/E25.37×
  • P/E 1 year forward21.37×
  • Forward PEG2.23×
  • Indicated annual dividend(U.S.) $0.45
  • Dividend yield1.04%
  • Trailing EPS(U.S.) $1.72
Updated June 30 4:02 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.20%Sector:Industry:

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue4,2054,3484,2314,199
Total other revenue--------
Total revenue4,2054,3484,2314,199
Gross profit1,3181,4681,3821,297
Total cost of revenue2,8882,8792,8502,901
Total operating expense3,6653,6863,6183,652
Selling / general / administrative785788770714
Research & development37403534
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income540662614547
Interest income (expense), net non-operating-116-125-106-115
Gain (loss) on sale of assets--------
Other--------
Income before tax435574514445
Income after tax297393346310
Income tax, total138180168135
Net income228317262241
Total adjustments to net income--------
Net income before extra. items228317262241
Minority interest-69-77-83-69
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items228317262241
Inc. avail. to common incl. extra. items228317262241
Diluted net income228317262241
Dilution adjustment0----0
Diluted weighted average shares306304305305
Diluted EPS excluding extraordinary itemsvalue per share0.751.040.860.79
Dividends per sharevalue per share0.000.000.000.87
Diluted normalized EPSvalue per share0.751.040.860.79